Impact of immediate TRUS rebiopsy in a patient cohort considering active surveillance for favorable risk prostate cancer

Impact of immediate TRUS rebiopsy in a patient cohort considering active surveillance for favorable risk prostate cancer

Abstract Introduction and Objective Active surveillance (AS) is an option for the management of favorable risk prostate cancer (CaP) in the PSA era. Published studies have reported variable inclusion criteria for cohort selection. Accurate assessment of individual patient risk in AS is dependent not...

Ausführliche Beschreibung

Gespeichert in:
Bibliographische Detailangaben
Veröffentlicht in:Urologic oncology 2013-08, Vol.31 (6), p.739-743
Hauptverfasser: King, Andre C., M.D, Livermore, Andrew, B.S, Laurila, Timo A.J., Ph.D, Huang, Wei, M.D, Jarrard, David F., M.D
Format: Artikel
Sprache:eng
Schlagworte:
Active surveillance
Aged
Biopsy - methods
Cohort Studies
Follow-Up Studies
Humans
Male
Middle Aged
Neoplasm Grading
Prostate - diagnostic imaging
Prostate cancer
Prostatic Neoplasms - diagnostic imaging
Prostatic Neoplasms - pathology
Regression Analysis
Reproducibility of Results
Risk
Treatment Outcome
TRUS biopsy
Ultrasonography - methods
Urology
Online-Zugang:Volltext
Tags: Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!
Beschreibung
Zusammenfassung:Abstract Introduction and Objective Active surveillance (AS) is an option for the management of favorable risk prostate cancer (CaP) in the PSA era. Published studies have reported variable inclusion criteria for cohort selection. Accurate assessment of individual patient risk in AS is dependent not only upon rigorous selection criteria, but also reliability of diagnosis at tissue biopsy. To date, the impact of immediate transrectal ultrasound (TRUS) rebiopsy in confirming candidates for AS has been incompletely defined. Methods From a total of over 567 men, 67 met criteria for AS (Gleason
ISSN:1078-1439
1873-2496
DOI:10.1016/j.urolonc.2011.06.011